SESSION TITLE: Pulmonary Embolism: Assessment and Outcomes
SESSION TYPE: Original Investigation Slide
PRESENTED ON: Sunday, October 23, 2016 at 04:30 PM - 05:30 PM
PURPOSE: Rivaroxaban is comparable to warfarin for the treatment of venous thromboembolism (VTE). We assessed the total healthcare costs up to 12 months following a VTE event among patients prescribed rivaroxaban or warfarin.